Filing Flows

Filing Flows › Beam Therapeutics (BEAM) › Next earnings date

Beam Therapeutics (BEAM) earnings: missed the estimate

Beam Therapeutics (BEAM) reported on Nov 3, 2026 and missed the EPS estimate: −$1.28 against −$1.17 (-9.4%). Revenue was $307K for Q3 2026, -97% year over year. It beat the EPS estimate in 40% of the quarters on record.

Last result−9.4% vs estimate
Beat rate40%

The last report

Beam Therapeutics reported revenue of $307K for the third quarter 2026 (-97% Y/Y), net loss $134M. How it makes money → · Every quarter →

Beam Therapeutics: EPS against the estimate, last 5 reportsBeam Therapeutics: EPS against the estimate, last 5 reportsEstimateReported−$1.01−$1.10Nov 25−$1.12$2.33Feb 26−$1.01−$0.91May 26−$1.13−$1.18Aug 26−$1.17−$1.28Nov 26
Latest (Nov 26): Estimate −$1.17, Reported −$1.28.

Beam Therapeutics' latest quarter

Beam Therapeutics, Q3 2026: revenue $307K (-97% year over year), net loss $134M, operating cash flow −$111M. The chart follows the revenue to costs, profit and cash.

Questions

Did Beam Therapeutics beat earnings?

Beam Therapeutics (BEAM) reported on Nov 3, 2026 and missed the EPS estimate: −$1.28 against −$1.17 (-9.4%).

When does BEAM report earnings?

The next date is not set yet.

Does Beam Therapeutics usually beat earnings?

It beat the consensus EPS estimate in 40% of the quarters on record.

Open the interactive view →

Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.